Background illustration for clinical trials search

Paid Clinical Trials Allentown

Discover 2,147 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee

for
Osteoarthritis
Location: Somerset NJ, Waterbury CT, Altoona PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07153471

Phase3, Recruiting

Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder

for
GRIN-related Neurodevelopmental Disorder
Location: Philadelphia PA, Hackensack NJ, New York NY,
Sponsor: GRIN Therapeutics, Inc.

Sex: All

Age: 0 - 18

Code: NCT07224581

Phase3, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Philadelphia PA, East Orange NJ, Flushing NY,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase3, Recruiting

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

for
Neuroblastoma
Location: Philadelphia PA, Columbus OH, Memphis TN, Dallas TX,
Sponsor: New Approaches to Neuroblastoma Therapy Consortium

Sex: All

Age: 1 - 31

Code: NCT06450041

Phase2, Recruiting

CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes

for
Type 2 Diabetes Mellitus (T2DM), Pregnancy,
Location: Philadelphia PA, Sewell NJ
Sponsor: Thomas Jefferson University

Sex: Female

Age: 18+

Code: NCT07184775

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

for
Advanced Or Metastatic Merkel Cell Carcinoma
Location: Morristown NJ, Hackensack NJ, Fairfax VA, Pittsburgh PA,
Sponsor: TuHURA Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT06947928

Phase2, Phase3, Recruiting

Next-Generation Photon-Counting CT Technology: Development and Clinical Evaluation

for
Radiation Protection, Image Enhancement
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18 - 70+

Code: NCT06691659

Recruiting

I-DECIDE After Bronchiolitis Hospitalization

for
Bronchiolitis Acute
Location: Philadelphia PA, Plainsboro NJ, Hackensack NJ,
Sponsor: Seattle Children's Hospital

Sex: All

Age: 0 - 2

Code: NCT07243652

Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

for
Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer,
Location: Philadelphia PA, Minneapolis MN, Houston TX,
Sponsor: Fate Therapeutics

Sex: All

Age: 18+

Code: NCT07216105

Phase1, Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Philadelphia PA, New York NY, New Haven CT, Fairfax VA,
Sponsor: EvolveImmune United, Inc

Sex: All

Age: 18+

Code: NCT07217171

Phase1, Recruiting

A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic Anemia

for
Autoimmune Haemolytic Anaemia
Location: Philadelphia PA, The Bronx NY, New Haven CT,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07086976

Phase3, Recruiting

Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy

for
Ig-E Mediated Food Allergy
Location: Philadelphia PA, New York NY, Great Neck NY,
Sponsor: RAPT Therapeutics, Inc.

Sex: All

Age: 12 - 55

Code: NCT07220811

Phase2, Recruiting

Neurobehavioral Changes Following Spaceflight Stressors

for
Stressor, Individual, Alcohol Impairment, Sleep Deprivation,
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 21 - 60

Code: NCT07293494

Recruiting

Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment

for
Recurrent Multiple Myeloma, Refractory Multiple Myeloma
Location: Philadelphia PA
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07463807

Phase1, Phase2, Recruiting

Diet and Motility in IBS

for
Irritable Bowel Syndrome (IBS)
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 8 - 18

Code: NCT07283341

Recruiting

DESTINY-PANTUMOUR04

for
Adenocarcinoma (NOS), Anal Cancer, Bladder Cancer,
Location: Philadelphia PA, Canton OH, Wilson NC, Durham NC,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07124000

Recruiting

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

for
Type 1 Diabetes
Location: Philadelphia PA, Buffalo NY, Charlottesville VA,
Sponsor: SAb Biotherapeutics, Inc.

Sex: All

Age: 5 - 40

Code: NCT07187531

Phase2, Recruiting

Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients

for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Location: Philadelphia PA, New Brunswick NJ, Atlanta GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 2 - 18

Code: NCT06934967

Phase3, Recruiting

A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

for
Geographic Atrophy
Location: Bethlehem PA, Hagerstown MD, Chevy Chase MD, Lemont IL,
Sponsor: Sanofi

Sex: All

Age: 60+

Code: NCT07215234

Phase1, Phase2, Recruiting

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Location: Philadelphia PA, Pittsburgh PA, Boston MA, Cleveland OH,
Sponsor: Amgen

Sex: Male

Age: 18+

Code: NCT07140900

Phase1, Recruiting